Perspective - Biology & Medicine Case Reports (2023) Volume 7, Issue 3

Computational approaches in medicinal chemistry for target identification and drug discovery.

Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, USA

*Corresponding Author:

Khoury Krause
Department of Epidemiology of Microbial Diseases
Yale School of Public Health, New Haven, USA
E-mail: houry@gmail.com

Received:01-May-2023, Manuscript No. aabmcr -23-104489; Editor assigned: 03-May-2023, Pre QC No. aabmcr -23-104489 (PQ); Reviewed: 17-May-2023, QC No. aabmcr -23- 104489; Revised: 20-May-2023, Manuscript No. aabmcr -23-104489 (R); Published: 26-May -2023, DOI: 10.35841/aabmcr-7.3.149

Citation: Krause K. Computational approaches in medicinal chemistry for target identification and drug discovery. Biol Med Case Rep. 2023;7(3):149

Introduction

Quantitative Structure-Activity Relationship (QSAR) Analysis: QSAR is a computational method used to establish a relationship between the chemical structure of a molecule and its biological activity. It involves the development of mathematical models that correlate the structural features of compounds to their observed biological activities. QSAR models can be used to predict the activity of new compounds and guide the design of more potent and selective drugs. Pharmacophore Modeling: Pharmacophore modeling is a technique used to identify the essential features in a molecule that are required for binding to a specific target. It involves the construction of a three-dimensional model representing the spatial arrangement of these features. Pharmacophore models can be used for virtual screening, lead optimization, and designing focused libraries of compounds with desired biological activities [1].

Structure-Based Drug Design (SBDD): SBDD involves the use of three-dimensional structural information of a target protein to guide the design of new drug molecules. It includes techniques such as protein-ligand docking, fragmentbased drug design, and de novo drug design. SBDD helps in understanding the interactions between drugs and their targets at a molecular level, facilitating the design of more potent and selective compounds.

Ligand-Based Drug Design (LBDD): LBDD approaches use the knowledge of active compounds and their structure-activity relationships to design new drugs. It includes techniques such as similarity searching, pharmacophore-based screening, and quantitative structure-activity relationship analysis. LBDD is particularly useful when the target protein structure is unknown or difficult to obtain These computational approaches, when combined with experimental techniques, accelerate the process of target identification and drug discovery. They help in prioritizing targets, screening large compound libraries, optimizing lead compounds, and designing novel molecules with desired properties, ultimately leading to the development of new therapeutic agents. [2].

Machine learning and artificial intelligence: Machine learning and artificial intelligence techniques are increasingly being employed in medicinal chemistry. These methods can analyze large amounts of data, identify patterns, and make predictions. They are used for diverse applications, including virtual screening, compound synthesis prediction, toxicity prediction, and de novo drug design. These computational approaches are often combined with experimental methods to facilitate the discovery and development of new drugs. They help in rational decision-making, lead optimization, and reducing the number of compounds that need to be synthesized and tested in the lab, ultimately accelerating the drug discovery process [3].

Computational approaches play a crucial role in target identification and drug discovery in medicinal chemistry. Here are some specific computational approaches used in these areas Target Identification: Computational methods can help identify potential drug targets by analyzing large-scale biological data. Some common approaches include

Genomics and proteomics analysis: Computational analysis of genomic and proteomic data can identify genes or proteins that are implicated in disease processes. This involves techniques such as differential gene expression analysis, network analysis, and pathway analysis. Systems Biology: Systems biology approaches integrate various types of biological data to understand the complex interactions within biological systems. Computational modeling and simulation are used to identify key components and pathways that play a role in disease and may serve as potential drug targets [4].

Network analysis: Network-based approaches analyze molecular interaction networks to identify key nodes or modules that are associated with disease. These approaches can uncover potential target proteins and their relationships with other molecules in the network. Virtual Screening: Virtual screening is a computational technique used to identify potential drug candidates that are likely to bind to a specific target of interest. It involves the screening of large compound libraries using various computational methods, such as molecular docking, pharmacophore-based screening, or machine learning-based approaches. Virtual screening helps in prioritizing compounds for experimental testing, reducing the time and cost required for lead identification [5].

Conclusion

Computational methods can be used to design new drug molecules from scratch. De novo drug design involves generating novel compounds that are likely to bind to a specific target using computational algorithms. This approach can be guided by knowledge of the target structure or by employing ligand-based or structure-based design strategies. QSAR models can be used to predict the activity of compounds against a target of interest. These models are built using computational algorithms that analyze the structure-activity relationships of known compounds. QSAR models can guide the design of new compounds with improved activity profiles.

References

1. Nayarisseri A. Experimental and computational approaches to improve binding affinity in chemical biology and drug discovery. Curr Top Med Chem. 2020;20(19):1651-60.

Indexed at, Google Scholar, Cross Ref

2. Ramsay RR, Popovic-Nikolic MR, Nikolic K, et al. A perspective on multi-target drug discovery and design for complex diseases. Clinical and translational medicine. 2018;7(1):1-4.

Indexed at, Google Scholar, Cross Ref

3. Tang Y, Zhu W, Chen K, et al. New technologies in computer-aided drug design: Toward target identification and new chemical entity discovery. Drug Discov. 2006;3(3):307-13.

Google Scholar

4. Shanmugam A, Muralidharan N, Velmurugan D, et al. Therapeutic targets and computational approaches on drug development for COVID-19. Curr Top Med Chem. 2020;20(24):2210-20.

Indexed at, Google Scholar, Cross Ref

5. Schenone M, Dancík V, Wagner BK, et al. Target identification and mechanism of action in chemical biology and drug discovery. Nat Chem Biol. 2013;9(4):232-40.

Indexed at, Google Scholar, Cross Ref